This evidence is in line with the EFSA statement and suggests that human carriers of ATP7B functional SNPs [65] exhibit higher than normal values of non-ceruloplasmin copper and are therefore prone to a copper susceptibility that can increase the risk of developing AD. This evidence concerns the gene ATP7B and Alzheimer disease.